Search - tctmd.com

Displaying 1 - 20 of 618

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

Presentation Cardiovascular Interventions 2025

The Future of Drug Coated Balloons: Moving on to De Novo Disease?

Presenter: Suhail Dohad

November 13, 2025

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

TCT 487: Percutaneous Coronary Intervention with Drug-Coated Balloons in de novo Lesions in Patients with Diabetes Mellitus: A Real-World Experience

Presenter: Victor Alfonso Jimenez Diaz

October 28, 2025

Presentation TCT 2025

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

Presenter: David Erlinge

October 28, 2025

Presentation TCT 2025

TCT 519: Sirolimus eluting balloon efficacy and safety. A prospective registry of large vs small vessels

Presenter: Marco Ferrone

October 28, 2025

Presentation TCT 2025

TCT 520: Revascularization in HBR Made Safer: Leveraging Sirolimus-DCB and SAPT

Presenter: Victor Alfonso Jimenez Diaz

October 28, 2025

Presentation TCT 2025

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

Presenter: Bo Song

October 28, 2025

Presentation TCT 2025

TCT 673: IVUS-Based Predictors of Peri-procedural Success and Failure in Drug-Coated Balloon–Only PCI: A Prespecified Subanalysis of the NATURE Trial

Presenter: Taku Asano

October 28, 2025

Presentation TCT 2025

TCT 524: DCB-based versus DES-only Strategy for De Novo CAD across CHIP risk categories

Presenter: Dong Oh Kang

October 28, 2025

Presentation TCT 2025

TCT 528: Sirolimus-Coated Balloon with Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 28, 2025

Presentation TCT 2025

TCT 527: AngiogRaphic pattErns and management straTegies for coRonary restEnosis following drug-coATed balloon angioplasty in de novo lesions: The RETREAT Registry

Presenter: Mauro Gitto

October 28, 2025

Presentation TCT 2025

TCT 529: Clinical Outcomes after Scoring-balloon and Sirolimus-eluting Balloon Strategy in Diffuse Small-vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Valery Ljubenov Gelev

October 28, 2025

Presentation TCT 2025

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

Presenter: Yuko Kiyohara

October 27, 2025

Presentation TCT 2025

Will Drug-coated Balloons Change the Interventional Approach to Complex Coronary Disease?

Presenter: Margaret B. McEntegart

October 27, 2025

Presentation TCT 2025

Comparison of Drug-Coated Versus Conventional Balloons for Treatment of Side Branches of Bifurcation Lesions: The OCVC-BIF Study

Presenter: Takayuki Ishihara

October 27, 2025

Presentation TCT 2025

TCT 515: Real-World Usage of a Prevail Paclitaxel-Coated Balloon Compared With Other Contemporary Drug-Coated Balloons for Diabetes Mellitus

Presenter: David Erlinge

October 27, 2025

Presentation TCT 2025

TCT 517: Safety and efficacy of sirolimus-coated drug balloons for percutaneous coronary interventions in a real-world cohort: Results from the Selution-SIROOP registry

Presenter: Matthias Bossard

October 27, 2025

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2025

The Future of Drug Coated Balloons: Moving on to De Novo Disease?

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

TCTMD’s Top 10 Most Popular Stories for October 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

TCT 487: Percutaneous Coronary Intervention with Drug-Coated Balloons in de novo Lesions in Patients with Diabetes Mellitus: A Real-World Experience

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

TCT 519: Sirolimus eluting balloon efficacy and safety. A prospective registry of large vs small vessels

TCT 520: Revascularization in HBR Made Safer: Leveraging Sirolimus-DCB and SAPT

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

TCT 673: IVUS-Based Predictors of Peri-procedural Success and Failure in Drug-Coated Balloon–Only PCI: A Prespecified Subanalysis of the NATURE Trial

TCT 524: DCB-based versus DES-only Strategy for De Novo CAD across CHIP risk categories

TCT 528: Sirolimus-Coated Balloon with Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease

TCT 527: AngiogRaphic pattErns and management straTegies for coRonary restEnosis following drug-coATed balloon angioplasty in de novo lesions: The RETREAT Registry

TCT 529: Clinical Outcomes after Scoring-balloon and Sirolimus-eluting Balloon Strategy in Diffuse Small-vessel Coronary Artery Disease (SCA-DEB Study)

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

Will Drug-coated Balloons Change the Interventional Approach to Complex Coronary Disease?

Comparison of Drug-Coated Versus Conventional Balloons for Treatment of Side Branches of Bifurcation Lesions: The OCVC-BIF Study

TCT 515: Real-World Usage of a Prevail Paclitaxel-Coated Balloon Compared With Other Contemporary Drug-Coated Balloons for Diabetes Mellitus

TCT 517: Safety and efficacy of sirolimus-coated drug balloons for percutaneous coronary interventions in a real-world cohort: Results from the Selution-SIROOP registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content